Switch to: References

Add citations

You must login to add citations.
  1. Overseeing Innovative Therapy without Mistaking it for Research: A Function-Based Model Based on Old Truths, New Capacities, and Lessons from Stem Cells.Patrick L. Taylor - 2010 - Journal of Law, Medicine and Ethics 38 (2):286-302.
    Innovative therapy is the name we give to novel medical interventions, radically different from the standard of care, provided in order to benefit a patient, rather than to acquire new knowledge. They are paradigmshifting, not incremental, responses to serious patient problems that standard medical care inadequately addresses. Innovative therapies are often devised by clinicians, not basic science researchers; they do not follow the linear model of basic research, to translation, to clinical research, to application. Instead, they come from thinking backwards (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  • Law, Science, and Innovation: Introduction to the Symposium.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Introduction.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Embryo Stem Cell Research: Ten Years of Controversy.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):191-203.
    Embryonic stem cell research has been a source of ethical, legal, and social controversy since the first successful culturing of human ESCs in the laboratory in 1998. The controversy has slowed the pace of stem cell science and shaped many aspects of its subsequent development. This paper assesses the main issues that have bedeviled stem cell progress and identifies the ethical fault lines that are likely to continue.The time is appropriate for such an assessment because the field is poised for (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  • Overseeing Innovative Therapy without Mistaking It for Research: A Function-Based Model Based on Old Truths, New Capacities, and Lessons from Stem Cells.Patrick L. Taylor - 2010 - Journal of Law, Medicine and Ethics 38 (2):286-302.
    Should innovative therapy occur only within a research paradigm and under institutional review board oversight? The health risks from current human embryonic stem cell clinical applications have raised again a fundamental question addressed first in papers submitted to inform the writing of the Belmont Report. Revisiting the thinking underlying the Belmont Report, together with examining changed circumstances since then, leads to a new model for overseeing innovative therapy based on its unique risks and context, important changes since the Belmont Report, (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  • Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders.Kirstin R. W. Matthews & Ana S. Iltis - 2015 - BMC Medical Ethics 16 (1):1-11.
    BackgroundIn 2004, patient advocate groups were major players in helping pass and implement significant public policy and funding initiatives in stem cells and regenerative medicine. In the following years, advocates were also actively engaged in Washington DC, encouraging policy makers to broaden embryonic stem cell research funding, which was ultimately passed after President Barack Obama came into office. Many advocates did this because they were told stem cell research would lead to cures. After waiting more than 10 years, many of (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Introduction.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.
  • Embryo Stem Cell Research: Ten Years of Controversy.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):191-203.
    This overview of 10 years of stem cell controversy reviews the moral conflict that has made ESCs so controversial and how this conflict plays itself out in the legal realm, focusing on the constitutional status of efforts to ban ESC research or ESC-derived therapies. It provides a history of the federal funding debate from the Carter to the Obama administrations, and the importance of the Raab memo in authorizing federal funding for research with privately derived ESCs despite the Dickey-Wicker ban (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  • How Smart are Smart Materials? A Conceptual and Ethical Analysis of Smart Lifelike Materials for the Design of Regenerative Valve Implants.Annelien L. Bredenoord, Carlijn V. C. Bouten, Karin R. Jongsma & Anne-Floor J. de Kanter - 2023 - Science and Engineering Ethics 29 (5):1-18.
    It may soon become possible not just to replace, but to re-grow healthy tissues after injury or disease, because of innovations in the field of Regenerative Medicine. One particularly promising innovation is a regenerative valve implant to treat people with heart valve disease. These implants are fabricated from so-called ‘smart’, ‘lifelike’ materials. Implanted inside a heart, these implants stimulate re-growth of a healthy, living heart valve. While the technological development advances, the ethical implications of this new technology are still unclear (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation